Session 12

 

Sunday, September 3
2:00 – 4:00 pm

Room 3

 

 

Role of immune system

 

Chairs: Markus Möhler (Germany) – Sheila K. Krishnadath (Netherlands)

Discussant: Salah-Eddin Al-Batran (Germany)

 

Immunology part:

• What is the role of innate immune system in esophageal cancer? Sheila K. Krishnadath (Netherlands)
• Can the role of adaptive immune system in esophageal cancer be specified? Bastian Dislich (Germany)
• Is there a role of Micro RNA in the immune response of esophageal cancer? Irit Ben-Aharon (Israel)
• Overcoming tumor-mediated immunosuppression in esophageal adenocarcinoma. Hans Schlösser (Germany)
• Is there a role for the Immunoscore in esophageal cancer? Rupert Langer (Switzerland)
  
  

Pathology part:

• Is there a specific immune response that drives metaplasia and cancer in the esophagus?
  Sheila K. Krishnadath (Netherlands)
  
  

Pathophysiology part:

• Which animal reflux-inflammation models are there for BE and EAC? Ines Gockel (Germany)
• Are there specific cytokines involved in metaplasia-dysplasia-cancer sequence of the esophagus?
  Gerardo Nardone (Italy)

 

Clinical part:

• Are there compounds that enhance the immune response in esophageal cancer patients?
  Irit Ben-Aharon (Israel)
• What are the signaling pathways that can be targeted with immunotherapies? Hans Schlösser (Germany)
• What is the current state of immunotherapy for esophageal cancer? Maria Alsina (Spain)
• What is the current state of combination immunotherapy? Hanoch Kashtan (Israel)